Immucor, Inc. (BLUD) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-10.1M
Depreciation and amortization	18.16M
Loss on retirement of fixed assets
Provision for doubtful accounts
Share-based compensation expense
Deferred income taxes
Excess tax (benefits) shortfall from share-based compensation	1.4M
Accrued refund of BioArray escrowed funds
Accounts receivable, trade	-3.43M
Income taxes	481K
Inventories	-3.92M
Other assets	-472K
Accounts payable	-4.07M
Deferred revenue	739K
Accrued expenses and other liabilities	-13.35M
Cash provided by operating activities
Purchases of property and equipment	-2.83M
Acquisition of businesses, net of cash acquired	-128K
Cash used in investing activities
Repurchase of common stock
Proceeds from exercise of stock options
Excess tax benefits (shortfall) from share-based compensation
Cash provided by (used in) financing activities
EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	-599K
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	10.26M
CASH AND CASH EQUIVALENTS AT END OF YEAR	9.66M
Tax paid	597K
Accrued refund of BioArray escrowed funds
Movement from inventory to property and equipment for instruments placed on rental agreements	1.56M

Entities mentioned with BLUD

View All Entities